Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents

Magnetic Resonance Imaging

Volumn 27, Issue 4, 2009, Pages 503-511

  Zong, Yuda ^a   Wang, Xuli ^a   Jeong, Eun Kee ^b   Parker, Dennis L ^b   Lu, Zheng Rong ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Biodegradable; Gadolinium; Magnetic resonance imaging; Polydisulfide contrast agents; Structure effect

Indexed keywords

CONTRAST MEDIUM; COPOLYMER; CYSTAMINE; CYSTINE; DISULFIDE; GADOLINIUM; GADOLINIUM PENTETATE; GLUTATHIONE; THIOL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CARDIOVASCULAR SYSTEM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISULFIDE BOND; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KINETICS; MACROMOLECULE; MAGNETIC RESONANCE ANGIOGRAPHY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STEREOSPECIFICITY; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; DISULFIDES; FEMALE; GADOLINIUM; IMAGE ENHANCEMENT; MACROMOLECULAR SUBSTANCES; MAGNETIC RESONANCE IMAGING; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

MUS;

EID: 63349108237     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2008.07.020     Document Type: Article

References (22)

1. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
2. Caravan P., Ellison J., McMurry T., and Lauffer R. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem Rev 99 (1999) 2293-2352
3. Brasch R., and Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol 34 (2000) 148-155
4. Duncan J.R., Franano F.N., Edwards W.B., and Welch M.J. Evidence of gadolinium dissociation from protein-DTPA-gadolinium complexes. Invest Radiol 29 Suppl 2 (1994) S58-S61
5. Franano F.N., Edwards W.B., Welch M.J., Brechbiel M.W., Gansow O.A., and Duncan J.R. Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: Evidence for gadolinium dissociation in vitro and in vivo. Magn Reson Imaging 13 (1995) 201-214
6. Lu Z.R., Mohs A.M., Zong Y., and Feng Y. Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents. Int J Nanomedicine 1 (2006) 31-40
7. Mohs A.M., and Lu Z.R. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential. Expert Opin Drug Deliv 4 (2007) 149-164
8. Lu Z.R., Wang X., Parker D.L., Goodrich K.C., and Buswell H.R. Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging. Bioconjug Chem 14 (2003) 715-719
9. Lu Z.R., Parker D.L., Goodrich K.C., Wang X., Dalle J.G., and Buswell H.R. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI. Magn Reson Med 51 (2004) 27-34
10. Wang X., Feng Y., Ke T., Schabel M., and Lu Z.R. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent. Pharm Res 22 (2005) 596-602
11. Zong Y., Wang X., Goodrich K.C., Mohs A.M., Parker D.L., and Lu Z.R. Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice. Magn Reson Med 53 (2005) 835-842
12. Zong Y., Guo J., Ke T., Mohs A.M., Parker D.L., and Lu Z.R. Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes. J Control Release 30 (2006) 350-356
13. Mohs A.M., Zong Y., Guo J., Parker D.L., and Lu Z.R. PEG-g-poly(GdDTPA-co-l-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI. Biomacromolecules 6 (2005) 2305-2311
14. Mohs A.M., Nguyen T., Jeong E.K., Feng Y., Emerson L., Zong Y., et al. Modification of Gd-DTPA cystine copolymers with PEG-1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography. Magn Reson Med 58 (2007) 110-118
15. Fukushima E., and Roeder S.B.W. Experimental pulse NMR: a nuts and bolts approach (1981), Addison-Wesley, Reading (Mass)
16. Mansoor M.A., Svardal A.M., and Ueland P.M. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in human plasma. Anal Biochem 200 (1992) 218-229
17. Mahieu J.P., Gosselet N.M., Sebille B., Garel M.C., and Beuzard Y. Reactivity of 42 disulfides with thiol group of human haemoglobin and human serum albumin. Int J Biol Macromol 15 (1993) 233-240
18. Thorpe P.E., Wallace P.M., Knowles P.P., Relf M.G., Brown A.N., Watson G.J., et al. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Res 47 (1987) 5924-5931
19. Greenfield L., Bloch W., and Moreland M. Thiol-containing cross-linking agent with enhanced steric hindrance. Bioconjug Chem 1 (1990) 400-410
20. Carroll S.F., Bernhard S.L., Goff D.A., Bauer R.J., Leach W., and Kung A.H. Enhanced stability in vitro and in vivo of immunoconjugates prepared with 5-methyl-2-iminothiolane. Bioconjug Chem 5 (1994) 248-256
21. Arpicco S., Dosio F., Brusa P., Crosasso P., and Cattel L. New coupling reagents for the preparation of disulfide cross-linked conjugates with increased stability. Bioconjug Chem 8 (1997) 327-337
22. Hupe D.J., and Wu D. Effect of charged substituents on rates of the thiol-disulfide interchange reaction. J Org Chem 45 (1980) 3100-3103